Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
East Carolina PA announcer will not let juvenile diabetes sluggish him down.
Scott Rogers was seated in the second row of the press compartment at East Carolina University's Clark LeClair Stadium, smiling.There was nerve around his...
Diabetes Prevention Program Units Informational Periods | Information, Sports activities, Jobs
Trinity Health is accepting registrations for Weigh 2 Change, a CDC-approved diabetes prevention program that allows people with prediabetes to take control of their...